{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 451563858
| IUPAC_name = (6aR,9R,10aR)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydrobenzo[c]chromene-1,9-diol
| image = HU-243_structure.png
| width = 200

<!--Clinical data-->
| tradename =  
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 56689-43-1
| ATC_prefix = none
| PubChem = 41969
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2105525
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = NZ1ZPC4WSF
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 16736847

<!--Chemical data-->
| C=24 | H=38 | O=3 
| molecular_weight = 374.555 g/mol
| smiles = Oc1cc(C(C)(C)CCCCCC)cc(c1C2C3)OC(C)(C)C2CCC3O
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C24H38O3/c1-6-7-8-9-12-23(2,3)16-13-20(26)22-18-15-17(25)10-11-19(18)24(4,5)27-21(22)14-16/h13-14,17-19,25-26H,6-12,15H2,1-5H3/t17?,18-,19-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = UEKGZFCGRQYMRM-MNNMKWMVSA-N
}}

'''Canbisol''' ('''Nabidrox'''), is a [[synthetic cannabinoid]] derivative that is the dimethylheptyl [[Homology (chemistry)|homologue]] of 9-''nor''-9β-hydroxyhexahydrocannabinol ([[9-nor-9β-Hydroxyhexahydrocannabinol|HHC]]). It is a potent [[agonist]] at both the [[Cannabinoid receptor 1|CB<sub>1</sub>]] and [[Cannabinoid receptor 2|CB<sub>2</sub>]] [[Receptor (biochemistry)|receptors]], with a [[Dissociation constant#Protein-ligand binding|binding affinity]] of 0.1nM at CB<sub>1</sub> and 0.2nM at CB<sub>2</sub>.<ref name="pmid9379442">{{cite journal |author=Rhee MH |title=Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase |journal=Journal of Medicinal Chemistry |volume=40 |issue=20 |pages=3228–33 |date=September 1997 |pmid=9379442 |doi=10.1021/jm970126f |url=|display-authors=etal}}</ref> It is mainly used in scientific research, in receptor binding studies to determine the structure and function of the [[cannabinoid]] receptors,<ref name="pmid11080201">{{cite journal |author=Rhee MH |title=Functional role of tryptophan residues in the fourth transmembrane domain of the CB(2) cannabinoid receptor |journal=Journal of Neurochemistry |volume=75 |issue=6 |pages=2485–91 |date=December 2000 |pmid=11080201 |doi= 10.1046/j.1471-4159.2000.0752485.x|url=|display-authors=etal}}</ref><ref name="pmid12514330">{{cite journal |author=Rhee MH |title=Functional role of serine residues of transmembrane dopamin VII in signal transduction of CB2 cannabinoid receptor |journal=Journal of Veterinary Science |volume=3 |issue=3 |pages=185–91 |date=September 2002 |pmid=12514330 |doi= |url=}}</ref><ref name="pmid15840841">{{cite journal |author=Zhang R |title=Cysteine 2.59(89) in the second transmembrane domain of human CB2 receptor is accessible within the ligand binding crevice: evidence for possible CB2 deviation from a rhodopsin template |journal=Molecular Pharmacology |volume=68 |issue=1 |pages=69–83 |date=July 2005 |pmid=15840841 |doi=10.1124/mol.104.007823 |url=|display-authors=etal}}</ref> but has been made illegal in some countries due to its possible abuse potential as a [[cannabinomimetic]] drug.<ref>[http://www.opsi.gov.uk/si/si2009/draft/ukdsi_9780111486610_en_1 The Misuse of Drugs Act 1971 (Amendment) Order 2009]</ref>

==See also==
* [[HU-210]]
* [[HU-243]]
* [[Nabilone]]

== References ==
{{Reflist}}

{{Cannabinoids}}
{{Cannabinoidergics}}

[[Category:Cannabinoids]]
[[Category:Benzochromenes]]
[[Category:Alcohols]]
[[Category:Phenols]]


{{cannabinoid-stub}}